Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
During World War II, Heidelberger became involved in an effort by military physicians to develop a pneumonia vaccine, consisting of a combination of purified polysaccharides of four specific pneumococcal types, for the immunization of troops. In this article, Heidelberger and one of his wartime collaborators, Colin MacLeod, along with two coauthors described improvements in their quantitative precipitin method for measuring the amount of type-specific anti-pneumococcal antibodies in human sera, measurements that revealed that an even smaller amount of the specific polysaccharide than used previously was sufficient for effective immunization. Additionally, the team provided data on various injection methods (subcutaneous vs. intracutaneous) and the duration of protection (antibody levels remained relatively constant for 5-8 months after injection).
Pneumococcal Infections, Polysaccharides, and Antibodies
Format:
Text
Extent:
18 pages
Language:
English
Legacy Source Citation:
Periodical. Heidelberger, Michael, Colin M. MacLeod, Samuel J. Kaiser, and Betty Robinson. "Antibody Formation in Volunteers Following Injection of Pneumococci or Their Type-Specific Polysaccharides." Journal of Experimental Medicine 83, 4 (March 1946): 303-320. Article. 18 Images.. Journal of Experimental Medicine